Antibody responses to SARS‐CoV‐2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti‐cancer therapies

Saved in:
Bibliographic Details
Published inBritish journal of haematology Vol. 198; no. 3; pp. 478 - 481
Main Authors Chan, Wei Yee, Zhu, Catherine, Sanchez, Emilie, Gupta, Rajeev, Fielding, Adele K., Khwaja, Asim, Payne, Elspeth M., O'Nions, Jenny
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.08.2022
John Wiley and Sons Inc
Subjects
Acute myeloid leukemia
Antibodies, Viral
Antibody Formation
Cancer therapies
COVID-19 - prevention & control
COVID-19 Vaccines
Covid‐19
Hematology
Humans
Letter to the Editor
Leukemia, Myeloid, Acute - drug therapy
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Vaccination
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.18248